Advertisement

Uncategorized

Hospitalizations in the U.S. for COVID-19, the flu and respiratory syncytial virus — collectively referred to as a "tripledemic" — are expected to peak at the end of January, according to the latest forecast from life science analytics company Airfinity. 

Advertisement

Intravenous hydromorphone has been acknowledged as an effective alternative for IV fentanyl in complex outpatient and ambulatory extended recovery cases, according to an Aug. 25 report from Anesthesiology News.

Using multimodal analgesia, comprising zopiclone, gabapentin and or celecoxib, did not improve results over the standard opioid-based approach in patients after undergoing hip arthroscopy, according to an Aug. 18 report from Anesthesiology News.

More than one-third of cases at Dallas-based United Surgical Partners International were orthopedic in 2022, according to a second-quarter report from Tenet, USPI's parent company. 

Advertisement